APO Research
Talk to an analyst

APO RESEARCH · REPORT

Calcineurin Inhibitor Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Calcineurin Inhibitor Drug Industry Research Report 2026

22 December 2025133 pages

Choose your research edition.

Industry ResearchCalcineurin Inhibitor Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Calcineurin Inhibitor Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Calcineurin Inhibitor Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Calcineurin Inhibitor Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Calcineurin Inhibitor Drug Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Calcineurin Inhibitor Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Calcineurin Inhibitor Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Calcineurin Inhibitor Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Calcineurin Inhibitor Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Calcineurin Inhibitor Drug include Sun Pharmaceutical Industries, Inc, Johnson & Johnson, Novartis AG, Mylan N.V., Pfizer Inc, AbbVie Inc, Wockhardt, Teva Pharmaceuticals Industries Inc, Veloxis Pharmaceuticals, Inc, and Mayne Pharma Group Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Calcineurin Inhibitor Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Calcineurin Inhibitor Drug Market by Company

Sun Pharmaceutical Industries, Inc

Johnson & Johnson

Novartis AG

Mylan N.V.

Pfizer Inc

AbbVie Inc

Wockhardt, Teva Pharmaceuticals Industries Inc

Veloxis Pharmaceuticals, Inc,

Mayne Pharma Group Limited

Leo Pharma A/S

Glenmark Pharmaceuticals Ltd

Dr. Reddy's Laboratories Ltd

Astellas Pharma Inc

Apotex Inc

Amneal Pharmaceuticals Inc

Allergan

Calcineurin Inhibitor Drug Segment by Type

Tacrolimus

Cyclosporine

Pimecrolimus

Others

Calcineurin Inhibitor Drug Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Calcineurin Inhibitor Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Calcineurin Inhibitor Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Calcineurin Inhibitor Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Calcineurin Inhibitor Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Calcineurin Inhibitor Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Calcineurin Inhibitor Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Calcineurin Inhibitor Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Calcineurin Inhibitor Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Calcineurin Inhibitor Drug Sales (k units) of Manufacturers (2021-2026) Table 7. Global Calcineurin Inhibitor Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Calcineurin Inhibitor Drug Revenue of Manufacturers (2021-2026) Table 9. Global Calcineurin Inhibitor Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Calcineurin Inhibitor Drug Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Calcineurin Inhibitor Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Calcineurin Inhibitor Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Calcineurin Inhibitor Drug, Product Type & Application Table 14. Global Calcineurin Inhibitor Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Calcineurin Inhibitor Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Sun Pharmaceutical Industries, Inc Company Information Table 19. Sun Pharmaceutical Industries, Inc Business Overview Table 20. Sun Pharmaceutical Industries, Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Sun Pharmaceutical Industries, Inc Calcineurin Inhibitor Drug Product Portfolio Table 22. Sun Pharmaceutical Industries, Inc Recent Developments Table 23. Johnson & Johnson Company Information Table 24. Johnson & Johnson Business Overview Table 25. Johnson & Johnson Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Johnson & Johnson Calcineurin Inhibitor Drug Product Portfolio Table 27. Johnson & Johnson Recent Developments Table 28. Novartis AG Company Information Table 29. Novartis AG Business Overview Table 30. Novartis AG Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Novartis AG Calcineurin Inhibitor Drug Product Portfolio Table 32. Novartis AG Recent Developments Table 33. Mylan N.V. Company Information Table 34. Mylan N.V. Business Overview Table 35. Mylan N.V. Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Mylan N.V. Calcineurin Inhibitor Drug Product Portfolio Table 37. Mylan N.V. Recent Developments Table 38. Pfizer Inc Company Information Table 39. Pfizer Inc Business Overview Table 40. Pfizer Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Pfizer Inc Calcineurin Inhibitor Drug Product Portfolio Table 42. Pfizer Inc Recent Developments Table 43. AbbVie Inc Company Information Table 44. AbbVie Inc Business Overview Table 45. AbbVie Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. AbbVie Inc Calcineurin Inhibitor Drug Product Portfolio Table 47. AbbVie Inc Recent Developments Table 48. Wockhardt, Teva Pharmaceuticals Industries Inc Company Information Table 49. Wockhardt, Teva Pharmaceuticals Industries Inc Business Overview Table 50. Wockhardt, Teva Pharmaceuticals Industries Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Wockhardt, Teva Pharmaceuticals Industries Inc Calcineurin Inhibitor Drug Product Portfolio Table 52. Wockhardt, Teva Pharmaceuticals Industries Inc Recent Developments Table 53. Veloxis Pharmaceuticals, Inc, Company Information Table 54. Veloxis Pharmaceuticals, Inc, Business Overview Table 55. Veloxis Pharmaceuticals, Inc, Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Veloxis Pharmaceuticals, Inc, Calcineurin Inhibitor Drug Product Portfolio Table 57. Veloxis Pharmaceuticals, Inc, Recent Developments Table 58. Mayne Pharma Group Limited Company Information Table 59. Mayne Pharma Group Limited Business Overview Table 60. Mayne Pharma Group Limited Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Mayne Pharma Group Limited Calcineurin Inhibitor Drug Product Portfolio Table 62. Mayne Pharma Group Limited Recent Developments Table 63. Leo Pharma A/S Company Information Table 64. Leo Pharma A/S Business Overview Table 65. Leo Pharma A/S Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Leo Pharma A/S Calcineurin Inhibitor Drug Product Portfolio Table 67. Leo Pharma A/S Recent Developments Table 68. Glenmark Pharmaceuticals Ltd Company Information Table 69. Glenmark Pharmaceuticals Ltd Business Overview Table 70. Glenmark Pharmaceuticals Ltd Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Glenmark Pharmaceuticals Ltd Calcineurin Inhibitor Drug Product Portfolio Table 72. Glenmark Pharmaceuticals Ltd Recent Developments Table 73. Dr. Reddy's Laboratories Ltd Company Information Table 74. Dr. Reddy's Laboratories Ltd Business Overview Table 75. Dr. Reddy's Laboratories Ltd Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dr. Reddy's Laboratories Ltd Calcineurin Inhibitor Drug Product Portfolio Table 77. Dr. Reddy's Laboratories Ltd Recent Developments Table 78. Astellas Pharma Inc Company Information Table 79. Astellas Pharma Inc Business Overview Table 80. Astellas Pharma Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Astellas Pharma Inc Calcineurin Inhibitor Drug Product Portfolio Table 82. Astellas Pharma Inc Recent Developments Table 83. Apotex Inc Company Information Table 84. Apotex Inc Business Overview Table 85. Apotex Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Apotex Inc Calcineurin Inhibitor Drug Product Portfolio Table 87. Apotex Inc Recent Developments Table 88. Amneal Pharmaceuticals Inc Company Information Table 89. Amneal Pharmaceuticals Inc Business Overview Table 90. Amneal Pharmaceuticals Inc Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Amneal Pharmaceuticals Inc Calcineurin Inhibitor Drug Product Portfolio Table 92. Amneal Pharmaceuticals Inc Recent Developments Table 93. Allergan Company Information Table 94. Allergan Business Overview Table 95. Allergan Calcineurin Inhibitor Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Allergan Calcineurin Inhibitor Drug Product Portfolio Table 97. Allergan Recent Developments Table 98. Global Calcineurin Inhibitor Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Calcineurin Inhibitor Drug Sales by Region (2021-2026) & (k units) Table 100. Global Calcineurin Inhibitor Drug Sales Market Share by Region (2021-2026) Table 101. Global Calcineurin Inhibitor Drug Sales by Region (2027-2032) & (k units) Table 102. Global Calcineurin Inhibitor Drug Sales Market Share by Region (2027-2032) Table 103. Global Calcineurin Inhibitor Drug Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Calcineurin Inhibitor Drug Revenue Market Share by Region (2021-2026) Table 105. Global Calcineurin Inhibitor Drug Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Calcineurin Inhibitor Drug Revenue Market Share by Region (2027-2032) Table 107. North America Calcineurin Inhibitor Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Calcineurin Inhibitor Drug Sales by Country (2021-2026) & (k units) Table 109. North America Calcineurin Inhibitor Drug Sales by Country (2027-2032) & (k units) Table 110. North America Calcineurin Inhibitor Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Calcineurin Inhibitor Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Calcineurin Inhibitor Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Calcineurin Inhibitor Drug Sales by Country (2021-2026) & (k units) Table 114. Europe Calcineurin Inhibitor Drug Sales by Country (2027-2032) & (k units) Table 115. Europe Calcineurin Inhibitor Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Calcineurin Inhibitor Drug Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Calcineurin Inhibitor Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Calcineurin Inhibitor Drug Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Calcineurin Inhibitor Drug Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Calcineurin Inhibitor Drug Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Calcineurin Inhibitor Drug Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Calcineurin Inhibitor Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Calcineurin Inhibitor Drug Sales by Country (2021-2026) & (k units) Table 124. South America Calcineurin Inhibitor Drug Sales by Country (2027-2032) & (k units) Table 125. South America Calcineurin Inhibitor Drug Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Calcineurin Inhibitor Drug Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Calcineurin Inhibitor Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Calcineurin Inhibitor Drug Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Calcineurin Inhibitor Drug Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Calcineurin Inhibitor Drug Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Calcineurin Inhibitor Drug Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Calcineurin Inhibitor Drug Sales by Type (2021-2026) & (k units) Table 133. Global Calcineurin Inhibitor Drug Sales by Type (2027-2032) & (k units) Table 134. Global Calcineurin Inhibitor Drug Sales Market Share by Type (2021-2026) Table 135. Global Calcineurin Inhibitor Drug Sales Market Share by Type (2027-2032) Table 136. Global Calcineurin Inhibitor Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Calcineurin Inhibitor Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Calcineurin Inhibitor Drug Revenue Market Share by Type (2021-2026) Table 139. Global Calcineurin Inhibitor Drug Revenue Market Share by Type (2027-2032) Table 140. Global Calcineurin Inhibitor Drug Price by Type (2021-2026) & (US$/unit) Table 141. Global Calcineurin Inhibitor Drug Price by Type (2027-2032) & (US$/unit) Table 142. Global Calcineurin Inhibitor Drug Sales by Application (2021-2026) & (k units) Table 143. Global Calcineurin Inhibitor Drug Sales by Application (2027-2032) & (k units) Table 144. Global Calcineurin Inhibitor Drug Sales Market Share by Application (2021-2026) Table 145. Global Calcineurin Inhibitor Drug Sales Market Share by Application (2027-2032) Table 146. Global Calcineurin Inhibitor Drug Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Calcineurin Inhibitor Drug Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Calcineurin Inhibitor Drug Revenue Market Share by Application (2021-2026) Table 149. Global Calcineurin Inhibitor Drug Revenue Market Share by Application (2027-2032) Table 150. Global Calcineurin Inhibitor Drug Price by Application (2021-2026) & (US$/unit) Table 151. Global Calcineurin Inhibitor Drug Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Calcineurin Inhibitor Drug Distributors List Table 155. Calcineurin Inhibitor Drug Customers List Table 156. Calcineurin Inhibitor Drug Industry Trends Table 157. Calcineurin Inhibitor Drug Industry Drivers Table 158. Calcineurin Inhibitor Drug Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Calcineurin Inhibitor Drug Product Image Figure 5. Global Calcineurin Inhibitor Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Calcineurin Inhibitor Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Calcineurin Inhibitor Drug Sales (2021-2032) & (k units) Figure 8. Global Calcineurin Inhibitor Drug Average Price (US$/unit) & (2021-2032) Figure 9. Tacrolimus Product Image Figure 10. Cyclosporine Product Image Figure 11. Pimecrolimus Product Image Figure 12. Others Product Image Figure 13. Hospital Pharmacies Product Image Figure 14. Online Pharmacies Product Image Figure 15. Retail Pharmacies Product Image Figure 16. Global Calcineurin Inhibitor Drug Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Calcineurin Inhibitor Drug, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Calcineurin Inhibitor Drug Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Calcineurin Inhibitor Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Calcineurin Inhibitor Drug Sales by Region in 2025 Figure 22. Global Calcineurin Inhibitor Drug Revenue by Region in 2025 Figure 23. North America Calcineurin Inhibitor Drug Market Size by Country in 2025 Figure 24. North America Calcineurin Inhibitor Drug Sales Market Share by Country (2021-2032) Figure 25. North America Calcineurin Inhibitor Drug Revenue Market Share by Country (2021-2032) Figure 26. United States Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Calcineurin Inhibitor Drug Market Size by Country in 2025 Figure 30. Europe Calcineurin Inhibitor Drug Sales Market Share by Country (2021-2032) Figure 31. Europe Calcineurin Inhibitor Drug Revenue Market Share by Country (2021-2032) Figure 32. Germany Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Calcineurin Inhibitor Drug Market Size by Country in 2025 Figure 43. Asia Pacific Calcineurin Inhibitor Drug Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Calcineurin Inhibitor Drug Revenue Market Share by Country (2021-2032) Figure 45. China Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Calcineurin Inhibitor Drug Market Size by Country in 2025 Figure 54. South America Calcineurin Inhibitor Drug Sales Market Share by Country (2021-2032) Figure 55. South America Calcineurin Inhibitor Drug Revenue Market Share by Country (2021-2032) Figure 56. Brazil Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Calcineurin Inhibitor Drug Market Size by Country in 2025 Figure 60. Middle East and Africa Calcineurin Inhibitor Drug Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Calcineurin Inhibitor Drug Revenue Market Share by Country (2021-2032) Figure 62. Egypt Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Calcineurin Inhibitor Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Calcineurin Inhibitor Drug Sales Market Share by Type (2021-2032) Figure 68. Global Calcineurin Inhibitor Drug Revenue Market Share by Type (2021-2032) Figure 69. Global Calcineurin Inhibitor Drug Price (US$/unit) by Type (2021-2032) Figure 70. Global Calcineurin Inhibitor Drug Sales Market Share by Application (2021-2032) Figure 71. Global Calcineurin Inhibitor Drug Revenue Market Share by Application (2021-2032) Figure 72. Global Calcineurin Inhibitor Drug Price (US$/unit) by Application (2021-2032) Figure 73. Calcineurin Inhibitor Drug Value Chain Figure 74. Calcineurin Inhibitor Drug Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Calcineurin Inhibitor Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tacrolimus
  • Cyclosporine
  • Pimecrolimus
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sun Pharmaceutical Industries, Inc
  • Johnson & Johnson
  • Novartis AG
  • Mylan N.V.
  • Pfizer Inc
  • AbbVie Inc
  • Wockhardt, Teva Pharmaceuticals Industries Inc
  • Veloxis Pharmaceuticals, Inc,
  • Mayne Pharma Group Limited
  • Leo Pharma A/S
  • Glenmark Pharmaceuticals Ltd
  • Dr. Reddy's Laboratories Ltd
  • Astellas Pharma Inc
  • Apotex Inc
  • Amneal Pharmaceuticals Inc
  • Allergan

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Calcineurin Inhibitor Drug Market Size (2021-2032)
  4. 2.2.2 Global Calcineurin Inhibitor Drug Sales (2021-2032)
  5. 2.2.3 Global Calcineurin Inhibitor Drug Market Average Price (2021-2032)
  6. 2.3 Calcineurin Inhibitor Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tacrolimus
  9. 2.3.3 Cyclosporine
  10. 2.3.4 Pimecrolimus
  11. 2.3.5 Others
  12. 2.4 Calcineurin Inhibitor Drug by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital Pharmacies
  15. 2.4.3 Online Pharmacies
  16. 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Calcineurin Inhibitor Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Calcineurin Inhibitor Drug Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Calcineurin Inhibitor Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Calcineurin Inhibitor Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Calcineurin Inhibitor Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Calcineurin Inhibitor Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Calcineurin Inhibitor Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Calcineurin Inhibitor Drug, Established Date
  9. 3.9 Global Calcineurin Inhibitor Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Sun Pharmaceutical Industries, Inc
  2. 4.1.1 Sun Pharmaceutical Industries, Inc Company Information
  3. 4.1.2 Sun Pharmaceutical Industries, Inc Business Overview
  4. 4.1.3 Sun Pharmaceutical Industries, Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Sun Pharmaceutical Industries, Inc Calcineurin Inhibitor Drug Product Portfolio
  6. 4.1.5 Sun Pharmaceutical Industries, Inc Recent Developments
  7. 4.2 Johnson & Johnson
  8. 4.2.1 Johnson & Johnson Company Information
  9. 4.2.2 Johnson & Johnson Business Overview
  10. 4.2.3 Johnson & Johnson Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Johnson & Johnson Calcineurin Inhibitor Drug Product Portfolio
  12. 4.2.5 Johnson & Johnson Recent Developments
  13. 4.3 Novartis AG
  14. 4.3.1 Novartis AG Company Information
  15. 4.3.2 Novartis AG Business Overview
  16. 4.3.3 Novartis AG Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novartis AG Calcineurin Inhibitor Drug Product Portfolio
  18. 4.3.5 Novartis AG Recent Developments
  19. 4.4 Mylan N.V.
  20. 4.4.1 Mylan N.V. Company Information
  21. 4.4.2 Mylan N.V. Business Overview
  22. 4.4.3 Mylan N.V. Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Mylan N.V. Calcineurin Inhibitor Drug Product Portfolio
  24. 4.4.5 Mylan N.V. Recent Developments
  25. 4.5 Pfizer Inc
  26. 4.5.1 Pfizer Inc Company Information
  27. 4.5.2 Pfizer Inc Business Overview
  28. 4.5.3 Pfizer Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pfizer Inc Calcineurin Inhibitor Drug Product Portfolio
  30. 4.5.5 Pfizer Inc Recent Developments
  31. 4.6 AbbVie Inc
  32. 4.6.1 AbbVie Inc Company Information
  33. 4.6.2 AbbVie Inc Business Overview
  34. 4.6.3 AbbVie Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 AbbVie Inc Calcineurin Inhibitor Drug Product Portfolio
  36. 4.6.5 AbbVie Inc Recent Developments
  37. 4.7 Wockhardt, Teva Pharmaceuticals Industries Inc
  38. 4.7.1 Wockhardt, Teva Pharmaceuticals Industries Inc Company Information
  39. 4.7.2 Wockhardt, Teva Pharmaceuticals Industries Inc Business Overview
  40. 4.7.3 Wockhardt, Teva Pharmaceuticals Industries Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Wockhardt, Teva Pharmaceuticals Industries Inc Calcineurin Inhibitor Drug Product Portfolio
  42. 4.7.5 Wockhardt, Teva Pharmaceuticals Industries Inc Recent Developments
  43. 4.8 Veloxis Pharmaceuticals, Inc,
  44. 4.8.1 Veloxis Pharmaceuticals, Inc, Company Information
  45. 4.8.2 Veloxis Pharmaceuticals, Inc, Business Overview
  46. 4.8.3 Veloxis Pharmaceuticals, Inc, Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Veloxis Pharmaceuticals, Inc, Calcineurin Inhibitor Drug Product Portfolio
  48. 4.8.5 Veloxis Pharmaceuticals, Inc, Recent Developments
  49. 4.9 Mayne Pharma Group Limited
  50. 4.9.1 Mayne Pharma Group Limited Company Information
  51. 4.9.2 Mayne Pharma Group Limited Business Overview
  52. 4.9.3 Mayne Pharma Group Limited Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mayne Pharma Group Limited Calcineurin Inhibitor Drug Product Portfolio
  54. 4.9.5 Mayne Pharma Group Limited Recent Developments
  55. 4.10 Leo Pharma A/S
  56. 4.10.1 Leo Pharma A/S Company Information
  57. 4.10.2 Leo Pharma A/S Business Overview
  58. 4.10.3 Leo Pharma A/S Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Leo Pharma A/S Calcineurin Inhibitor Drug Product Portfolio
  60. 4.10.5 Leo Pharma A/S Recent Developments
  61. 4.11 Glenmark Pharmaceuticals Ltd
  62. 4.11.1 Glenmark Pharmaceuticals Ltd Company Information
  63. 4.11.2 Glenmark Pharmaceuticals Ltd Business Overview
  64. 4.11.3 Glenmark Pharmaceuticals Ltd Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Glenmark Pharmaceuticals Ltd Calcineurin Inhibitor Drug Product Portfolio
  66. 4.11.5 Glenmark Pharmaceuticals Ltd Recent Developments
  67. 4.12 Dr. Reddy's Laboratories Ltd
  68. 4.12.1 Dr. Reddy's Laboratories Ltd Company Information
  69. 4.12.2 Dr. Reddy's Laboratories Ltd Business Overview
  70. 4.12.3 Dr. Reddy's Laboratories Ltd Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dr. Reddy's Laboratories Ltd Calcineurin Inhibitor Drug Product Portfolio
  72. 4.12.5 Dr. Reddy's Laboratories Ltd Recent Developments
  73. 4.13 Astellas Pharma Inc
  74. 4.13.1 Astellas Pharma Inc Company Information
  75. 4.13.2 Astellas Pharma Inc Business Overview
  76. 4.13.3 Astellas Pharma Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Astellas Pharma Inc Calcineurin Inhibitor Drug Product Portfolio
  78. 4.13.5 Astellas Pharma Inc Recent Developments
  79. 4.14 Apotex Inc
  80. 4.14.1 Apotex Inc Company Information
  81. 4.14.2 Apotex Inc Business Overview
  82. 4.14.3 Apotex Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Apotex Inc Calcineurin Inhibitor Drug Product Portfolio
  84. 4.14.5 Apotex Inc Recent Developments
  85. 4.15 Amneal Pharmaceuticals Inc
  86. 4.15.1 Amneal Pharmaceuticals Inc Company Information
  87. 4.15.2 Amneal Pharmaceuticals Inc Business Overview
  88. 4.15.3 Amneal Pharmaceuticals Inc Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Amneal Pharmaceuticals Inc Calcineurin Inhibitor Drug Product Portfolio
  90. 4.15.5 Amneal Pharmaceuticals Inc Recent Developments
  91. 4.16 Allergan
  92. 4.16.1 Allergan Company Information
  93. 4.16.2 Allergan Business Overview
  94. 4.16.3 Allergan Calcineurin Inhibitor Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Allergan Calcineurin Inhibitor Drug Product Portfolio
  96. 4.16.5 Allergan Recent Developments
5 Global Calcineurin Inhibitor Drug Market Scenario by Region
  1. 5.1 Global Calcineurin Inhibitor Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Calcineurin Inhibitor Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Calcineurin Inhibitor Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Calcineurin Inhibitor Drug Sales by Region: 2027-2032
  5. 5.3 Global Calcineurin Inhibitor Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Calcineurin Inhibitor Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Calcineurin Inhibitor Drug Revenue by Region: 2027-2032
  8. 5.4 North America Calcineurin Inhibitor Drug Market Facts & Figures by Country
  9. 5.4.1 North America Calcineurin Inhibitor Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Calcineurin Inhibitor Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Calcineurin Inhibitor Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Calcineurin Inhibitor Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Calcineurin Inhibitor Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Calcineurin Inhibitor Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Calcineurin Inhibitor Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Calcineurin Inhibitor Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Calcineurin Inhibitor Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Calcineurin Inhibitor Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Calcineurin Inhibitor Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Calcineurin Inhibitor Drug Market Facts & Figures by Country
  41. 5.7.1 South America Calcineurin Inhibitor Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Calcineurin Inhibitor Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Calcineurin Inhibitor Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Calcineurin Inhibitor Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Calcineurin Inhibitor Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Calcineurin Inhibitor Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Calcineurin Inhibitor Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Calcineurin Inhibitor Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Calcineurin Inhibitor Drug Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Calcineurin Inhibitor Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Calcineurin Inhibitor Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Calcineurin Inhibitor Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Calcineurin Inhibitor Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Calcineurin Inhibitor Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Calcineurin Inhibitor Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Calcineurin Inhibitor Drug Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Calcineurin Inhibitor Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Calcineurin Inhibitor Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Calcineurin Inhibitor Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Calcineurin Inhibitor Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Calcineurin Inhibitor Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Calcineurin Inhibitor Drug Value Chain Analysis
  2. 8.1.1 Calcineurin Inhibitor Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Calcineurin Inhibitor Drug Production Mode & Process
  5. 8.2 Calcineurin Inhibitor Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Calcineurin Inhibitor Drug Distributors
  8. 8.2.3 Calcineurin Inhibitor Drug Customers
9 Global Calcineurin Inhibitor Drug Analyzing Market Dynamics
  1. 9.1 Calcineurin Inhibitor Drug Industry Trends
  2. 9.2 Calcineurin Inhibitor Drug Industry Drivers
  3. 9.3 Calcineurin Inhibitor Drug Industry Opportunities and Challenges
  4. 9.4 Calcineurin Inhibitor Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst